Skip to content

Siddha Medicine for Uthiravadha Suronitham (Rheumatoid Arthiritis )

A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA HERBO MINERAL FORMULATION RAJA LOGA NATHA RASA PARPAM INTERNAL and AATTHIRADHI THAILAM EXTERNAL IN UTHIRAVATHASURONITHAM RHEUMATOID ARTHRITIS

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/10/002058
Enrollment
40
Registered
2011-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Rhematoid Arthritis (Uthira Vatha Suronitham)

Interventions

Intervention1: 1.Raja loga natha rasa parpam(Internal) 2.Aathiradhi thailam (External): 1.250 mgs bid with pepper powder and cows ghee 2.2 drops in each nostrils (Nasiyam) and also external applicatio

Sponsors

NATIONAL INSTITUTE OF SIDDHA
Lead Sponsor
NATIONAL INSTITUTE OF SIDDHA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ? Symmetrical joint involvement ? Arthritis of 3 or more joints ? Rheumatoid factor positive or negative ? Morning stiffness. ? Swelling especially in the inter-phalangeal joint. ? Patients who are willing for admission and stay in IPD for 48 days or willing to attend OPD

Exclusion criteria

Exclusion criteria: ? Hypertension and other Cardiac ailments ? Diabetes mellitus ? Narcotics ? Alcoholics and smokers. ? Pregnancy and lactation ? History of trauma ? Neurological disorder ? Tuberculosis ? Any other serious illness ? Psoriatic arthritis ? Gouty arthritis

Design outcomes

Primary

MeasureTime frame
The outcome is aimed at reducing the pain and restricted joint movements. Pain is assessed by Universal pain assessment scale. Timepoint: 0th day and 49th day

Secondary

MeasureTime frame
ESR,RA factor,CRPTimepoint: 0TH AND 49TH DAY

Countries

India

Contacts

Public ContactDrRSRamaswamy

NATIONAL INSTITUTE OF SIDDHA

dr.rsramaswamy@gmail.com9444941489

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026